Assessment of neurological disorders in patients with chronic viral hepatitis: A prospective cohort study
Article Sidebar
Main Article Content
Abstract
This prospective cohort study aimed to determine the prevalence and factors associated with neurological manifestations in patients with chronic hepatitis. The study involved 233 patients with chronic viral hepatitis from the Shymkent City Infectious Diseases Hospital and the Hepatological Center of the Shymkent Regional Clinical Hospital, conducted between March 2021 and January 2022. To identify neurological disorders, the neurological status of patient was assessed. The prevalence of neurological manifestations in the study population was 49.4%, which 43% of cases involving disorders of the peripheral nervous system. Peripheral neuropathy was common, affecting nearly half of the patients (49.4%). Factors associated with neurological manifestations included age over 50 years disease duration (greater than 5 years) alanine aminotransferase (ALT) level (p < 0.014), and aspartate aminotransferase (AST) level above 40 IU/L. Thus, patients with chronic viral hepatitis exhibit a range of neurological manifestations. We recommend routine screening for neurological disorders, particularly among older patient and those with a longer disease duration.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Adinolfi, L. E., Nevola, R., Lus, G., Restivo, L., Guerrera, B., Romano, C., Zampino, R., Rinaldi, L., Sellitto, A., Giordano, M., and Marrone, A. (2015). Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview. World Journal of Gastroenterology, 21(8), 2269–2280.
Basnayake, S. K., and Easterbrook, P. J. (2016). Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature. Journal of Viral Hepatitis, 23(7), 545–559.
Biasiotta, A., Casato, M., La Cesa, S., Colantuono, S., Di Stefano, G., Leone, C., Carlesimo, M., Piroso, S., Cruccu, G., and Truini, A. (2014). Clinical, neurophysiological, and skin biopsy findings in peripheral neuropathy associated with hepatitis C virus-related cryoglobulinemia. Journal of Neurology, 261(4), 725–731.
Boglione, L., Lupia, T., Cariti, G., and Di Perri, G. (2020). Efficacy and safety of interferon-free regimens in patients affected by chronic hepatitis C and psychiatric disorders. Journal of Infection and Chemotherapy, 26(1), 18–22.
Cacoub, P. (2016). Extrahepatic manifestations of chronic hepatitis C virus infection. Therapeutic Advances in Infectious Disease, 3(1), 3–14.
Choi, H.-Y., Mai, T. H., Kim, K.-A., Cho, H., and Ki, M. (2020). Association between viral hepatitis infection and Parkinson's disease: A population-based prospective study. Journal of Viral Hepatitis, 27(11), 1171–1178.
European Association for the Study of the Liver. (2018). EASL Recommendations on treatment of hepatitis C 2018. Journal of Hepatology, 69(2), 461–511.
Ferro, J. M., Viana, P., and Santos, P. (2016). Management of neurologic manifestations in patients with liver disease. Current Treatment Options in Neurology, 18(8), 37.
Flores-Chávez, A., Carrion, J. A., Forns, X., and Ramos-Casals, M. (2017). Extrahepatic manifestations associated with Chronic Hepatitis C Virus Infection. Revista Española de Sanidad Penitenciaria, 19(3), 87–97.
Grignoli, R., Goossens, N., and Negro, F. (2015). Extrahepatic manifestations of HCV. Minerva Gastroenterol Dietol, 61(1), 31–38.
Goldstein, L., Fogel-Grinvald, H., and Steiner, I. (2019). Hepatitis B and C virus infection as a risk factor for Parkinson's disease in Israel-A nationwide cohort study. Journal of the Neurological Sciences, 398, 138–141.
Iriana, S., Curry, M. P., and Afdhal, N. H. (2017). Neurologic manifestations of hepatitis C virus infection. Clinical Liver Disease, 21(3), 535–542.
Jumabayeva, A., Nersesov, A., Kulzhanov, M., Nefedova, M., Nuraliyeva, G., Rakhimbekova, G., Tanabayeva, S., and Fakhradiyev, I. (2022). Prevalence of viral hepatitis B, C, and D in Kazakhstan. Scientific World Journal, 2022, 9102565.
Mapoure, N. Y., Budzi, M. N., Eloumou, S. A. F. B., Malongue, A., Okalla, C., and Luma, H. N. (2018). Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study. PLoS One, 13(3), e0192406.
Mathew, S., Faheem, M., Ibrahim, S. M., Iqbal, W., Rauff, B., Fatima, K., and Qadri, I. (2016). Hepatitis C virus and neurological damage. World Journal of Hepatology, 8(12), 545–556.
Negro, F., Forton, D., Craxì, A., Sulkowski, M. S., Feld, J. J., and Manns, M. P. (2015). Extrahepatic morbidity and mortality of chronic hepatitis C. Gastroenterology, 149(6), 1345–1360.
Polaris Observatory HCV Collaborators. (2022). Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: A modelling study. Lancet Gastroenterol Hepatol, 7(5), 396–415.
Polukchi, T. V., Abuova, G. N., and Slavko, Y. A. (2023). The neuropsychiatric aspect of the chronic viral hepatitis. Prague Medical Report, 124(2), 94–107.
Polukchi, T. V., and Slavko, Y. A. (2023). Viral hepatitis B and C and neurological impairment. Ankara Medical Journal, 23(4), 468–477.
Ramamurthy, M., Sankar, S., Nandagopal, B., Sridharan, G., and Risbud, A. R. (2017). Viral diseases of public health importance in India: Current priorities with special emphasis on prevention. Journal of Krishna Institute of Medical Sciences University, 6(4), 1–11.
Schwendimann, R. N., and Minagar, A. (2017). Liver disease and neurology. Continuum, 23(3, Neurology of Systemic Disease), 762–777.
Sherman, A. C., and Sherman, K. E. (2015). Extrahepatic manifestations of hepatitis C infection: Navigating CHASM. Current HIV/AIDS Reports, 12(3), 353–361.
Sonavane, A. D., Saigal, S., Kathuria, A., Choudhary, N. S., and Saraf, N. (2018). Guillain-Barré syndrome: Rare extra-intestinal manifestation of hepatitis B. Clinical Journal of Gastroenterology, 11(4), 312–314.
Stockdale, A. J., Kreuels, B., Henrion, M. Y. R., Giorgi, E., Kyomuhangi, I., de Martel, C., Hutin, Y., and Geretti, A. M. (2020). The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. Journal of Hepatology, 73(3), 523–532.
Tassi, A., Gitto, S., Piras, C., Cursaro, C., Alicandro, T., Margotti, M., Rivi, M., and Andreone, P. (2021). Cognitive, neurological and psychiatric disorders occurring in Hepatitis C Virus infection. Minerva Medica, 112(2), 238–245.
Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K.-M., Hwang, J. P., Jonas, M. M., Brown, R. S. Jr., Bzowej, N. H., and Wong, J. B. (2018). Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology, 67(4), 1560–1599.
Wei, J., and Duan, S. (2021). Severe Guillain-Barré syndrome associated with chronic hepatitis B: A case report and literature review. Medicine (Baltimore), 100(48), e27989.
Wijarnpreecha, K., Chesdachai, S., Jaruvongvanich, V., and Ungprasert, P. (2018). Hepatitis C virus infection and risk of Parkinson's disease: A systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology, 30(1), 9–13.
Wu, W. Y.-Y., Kang, K.-H., Chen, S. L.-S., Chiu, S. Y.-H., Yen, A. M.-F., Fann, J. C-Y., Su, C.-W., Liu, H.-C., Lee, C.-Z., Fu, W.-M., Chen, H.-H., and Liou, H.-H. (2015). Hepatitis C virus infection: A risk factor for Parkinson's disease. Journal of Viral Hepatitis, 22(10), 784–791.
Zangeneh, M., Mesgarian, M., and Khosravani-Nezhad, Y. (2022). Association of acute hepatitis B and acute myopathy: A case report. Journal of Medical Case Reports, 16(1), 143.
Zanone, M. M., Marinucci, C., Ciancio, A., Cocito, D., Zardo, F., Spagone, E., Ferrero, B., Cerruti, C., Charrier, L., Cavallo, F., Saracco, G. M., and Porta, M. (2021). Peripheral neuropathy after viral eradication with direct-acting antivirals in chronic HCV hepatitis: A prospective study. Liver International, 41(11), 2611–2621.